Regulations.gov document
Developing and Using Precision Therapies in the ‘‘Omics’’ Era: Generating and Interpreting…
Notice · FDA-2014-N-0001 · posted Nov 21, 2014
Key facts
| Document ID | FDA-2014-N-0001-0097 |
|---|---|
| Title | Developing and Using Precision Therapies in the ‘‘Omics’’ Era: Generating and Interpreting Evidence for Rare Subsets; Public Workshop |
| Document type | Notice |
| Subtype | Meeting |
| Agency | FDA |
| Docket | FDA-2014-N-0001 |
| Posted | Nov 21, 2014 |
| Federal Register citation | 79 FR 69497 |
| FR document number | 2014-27523 |
| Comment period opens | Nov 21, 2014 |
| Effective date | Nov 21, 2014 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: